Ureterolithiasis

MECHANICSBURG, Pa., June 16, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Joe Littlejohn, Jr. is acknowledged as a Top Pinnacle Professional for his contributions to the field of Medical Technology and Urology. Continue Reading Joe Littlejohn Jr., MD (PRNewsfoto/The Inner Circle) Dr. Littlejohn Jr. began his medical academic journey at the University of Connecticut School of Medicine in 1995 where he earned a medical degree and also completed an internship in general surgery in 1997. He finished a residency in general surgery at the University of Connecticut Health Center also in 1997; completed a residency in urology at Howard University Hospital (District of Columbia) in 2001; and a fellowship in neuro-urology and voiding dysfunction at New York-Presbyterian Hospital in 2002. According to the doctor, urology is the branch of medicine that focuses on surgical and medical diseases of the male and female urinary-tract system and the male reproductive organs. Urologists specialize in diseases of the urinary tract and the male reproductive system. Patients may be referred to a urologist if their physician suspects they may need treatment for a condition relating to the bladder, prostate urethra, ureters, kidneys and adrenal glands. Specialized in diseases of the urinary tract and the male reproductive system, Dr. Littlejohn, Jr. areas of expertise include benign prostatic hypertrophy; general urology; neuromodulation therapies; robotic (da Vinci) surgery; urodynamics; bladder prolapse surgery; neurogenic bladder dysfunction; prostate cancer; ureteral stones; and voiding dysfunction. In addition to Dr. Littlejohn, Jr.'s professional medical career, he founded LinkBox Solutions LLC, a health technology company that seeks to incorporate the latest technological advances into the field of medicine. He was inspired to launch this business when he struggled to create a solution to help doctors more efficiently see their patients while also increasing quality of care. The doctor asserts that LinkBox Solutions LLC offers a mobile software system that removes barriers between the physician and their patients while automating the HPI documentation process. According to Dr. Littlejohn, Jr., this user-friendly technology allows a practice to receive detailed information about their patients before their appointment making patient care easier and faster than ever before. The program works as a mobile scribe ensuring doctors have access to all necessary data the moment, they need it. LinkBox generates question sets that are sent to the patients by the scheduling staff the moment their appointment is made (via email to register at their HIPAA/HITECH compliant cyber-secure site). This data collection method assures that all necessary information and relevant concerns are listed in one easily accessible location. Touted to increase the quality of patient care and decrease physician burnout, Dr. Littlejohn, Jr. explained that LinkBox streamlines daily operations and helps doctors feel more on top of their work while collaborating with EMR systems with its time-saving features, unparalleled privacy settings, and notes. Aside from his medical career, Dr. Littlejohn, Jr. serves as an Assistant Professor of Surgery within the Department of Urology at Penn State Health Milton S. Hershey Medical Center. He is Vice Chair of DEI within the Department of Urology at Penn State Health Technology and is Director of Telehealth within the Department of Urology at Penn State Health. The doctor offers his services at Penn State Health Surgery Specialties (Hershey Pennsylvania) & Penn State Health Medical Group Camp Hill Specialties. Dedicated to providing the latest advancements, Dr. Littlejohn Jr. is a member of the National Medical Association; the American Urological Association; the Mid-Atlantic Section of the American Urological Association; the Society of Urodynamics Female Pelvic Medicine & Urogenital Reconstruction; and is a Diplomate of the American Board of Urology. Fluent in English and Spanish, Dr. Littlejohn Jr. attributes his success to his belief in God and his Christian Faith and is upfront and honest regarding health-related matters. He would like to dedicate this honor to his mentor, Dr. Aaron G. Jackson, and In Memoriam of Master James A. Wilson and Dr. Steven Kaplan, as well as his grandfather, Quincy R. Littlejohn, in loving memory, and thanks him for his love and support. Contact: Katherine Green, 516-825-5634, [email protected] SOURCE The Inner Circle

A new technique which combines the use of two ultrasound technologies may offer an option to move kidney stones out of the ureter with minimal pain and no anesthesia, according to a new feasibility study. A new technique which combines the use of two ultrasound technologies may offer an option to move kidney stones out of the ureter with minimal pain and no anesthesia, according to a new feasibility study published today in The Journal of Urology. In the procedure, the physician uses a handheld transducer placed on the skin to direct ultrasound waves towards the stone. The ultrasound can then be used to move and reposition the stones to promote their passage, a process called ultrasound propulsion, or the break up the stone, a technique called burst wave lithotripsy (BWL). Unlike shock wave lithotripsy, which is the standard procedure now in use and requires sedation, this technology doesn't hurt, said lead author Dr. M. Kennedy Hall, a UW Medicine emergency medicine doctor. "It's nearly painless, and you can do it while the patient is awake, and without sedation, which is critical." The research team hopes that, with this new technology, the procedure of moving or breaking up the stones could eventually be performed in a clinic or emergency room setting, Hall added. Stones in the ureter, which leads from the kidney to the bladder, can cause severe pain and are a common reason for emergency department visits. Most patients with ureteral stones are advised to wait to see if the stone will pass on its own. However, this observation period can last for weeks, with nearly one-fourth of patients eventually requiring surgery, Hall noted. One in 11 Americans will have a urinary stone over the course of their lifetime. The incidence appears to be increasing, according to one UW Medicine study looking at this same technology. Up to 50% of patients with a stone event will recur within five years, the study noted. Hall and colleagues evaluated the new technique to meet the need for a way to treat stones without surgery. The study was designed to test the feasibility of using the ultrasonic propulsion or using BWL to break up stones in awake, unanaesthetized patients, Hall said. Twenty-nine patients participated in the study. Sixteen were treated with propulsion alone and 13 with propulsion and burst wave lithotripsy. In 19 patients, the stones moved. In two cases, the stones moved out of the ureter and into the bladder. Burst wave lithotripsy fragmented the stones in seven of the cases. At a two-week follow up, 18 of 21 patients (86%) whose stones were located lower in the ureter, closer to the bladder, had passed their stones. In this group, the average time to stone passage was about four days, the study noted. One of these patients felt "immediate relief" when the stone was dislodged from the ureter, the study stated. The next step for the researchers would be to perfom a clinical trial with a control group, which would not receive either BWL bursts or ultrasound propulsion, to evaluate the degree to which this new technology potentially aids stone passage, Hall said. Development of this technology first started five years ago, when NASA funded a study to see if kidney stones could be moved or broken up, without anesthesia, on long space flights, such as the Mars missions. The technology has worked so well that NASA has downgraded kidney stones as a key concern. "We now have a potential solution for that problem," Hall said. This study began in 2018 and was conducted on patients at Harborview Medical Center, University of Washington Medical Center-Montlake and the Northwest Kidney Stone Center at University of Washington Medical Center-Northwest. It involved the University of Washington School of Medicine's departments of emergency medicine, urology and radiology, and the UW Applied Physics Laboratory. Other UW Medicine trials have looked at breaking apart kidney stones inside the kidneys. This is the first trial to look at moving the stones or breaking them apart in the ureter with BWL, Hall said.

By End User, Hospitals Are Expected To Account For Bulk Of The Demand For Lithotripsy Devices To Address Gall Bladder & Kidney Stones Fact.MR – A Market Research and Competitive Intelligence Provider: The global lithotripsy market is expected to witness US $ 2 Billion by 2031 and is anticipated to grow at a rapid pace of 5% during forecast period. The market is driven by high prevalence of urolithiasis, surge in the number of extracorporeal shock waves lithotripsy operations, and technical developments in the medical industry. Historically, sales of lithotripsy devices grew at approximately 4% CAGR from 2016 to 2020. The recurrence and prevalence of kidney stone disorders are rising across the globe. Moreover, urolithiasis is expected to impact 12% of the world's population at some point in their lives. Moreover, as per the European Association of Urology, the prevalence of this illness has been expected to be more than 10% in nations with high standards of living such as Canada, United States and Sweden. Besides this, the rapid use of minimally invasive methods in various general surgeries, as well as their lower risk of complications, anticipated to boost the demand of lithotripsy equipment. For more insights into the Market, Request Brochure of this Report Moreover, methods such as laser surgeries are becoming common, which are expected to heighten prospects for the market. Also, surge in stone illnesses have led to increased adoption of lithotripsy. Besides this, emergence of innovative procedures and equipment in the treatment of stone diseases is expected to drive solutions for patients and healthcare practitioners. In addition to this, many regions across the globe, have been witnessing greater emphasis on replacing and updating hospital infrastructure, which will ultimately results in high usage of lithotripsy equipment in the coming years. Key Takeaways: Sales of lithotripsy devices in the US are expected to grow at a CAGR of around 5% until 2031. Moreover, with surge in prevalence of renal illness, over 50,000 lithotripsy surgeries are performed in the United States every year, further fuelling the market for lithotripsy devices. Asia is the fastest growing market and is projected to witness impressive growth due to considerable unmet medical needs. Moreover, countries such as China, India and Japan are expected to be the frontrunners of the higher demand. Hospitals have accounted for bulk of the demand for lithotripsy devices. Moreover, higher frequency of hospital visits to address various diseases such as gall bladder stones and kidney stones are boosting demand. Moreover, a revenue share of over 50% is anticipated for this segment. Growth Drivers: High prevalence of diseases such as Urinary Tract Infection has boosted the demand for lithotripsy technologies. High investments in hospital infrastructure in various developed econmoies, which will result in high usage of lithotripsy equipment during forecast period. These factors are expected to act as growth driver for the market. Clinicians have been adopting various advanced lithotripsy devices such as extracorporeal shock wave lithotripsy. These devices are gaining traction due to various benefits such as reduced discomfort, low invasiveness, shorter hospital stays, and faster recovery time. For Comprehensive Insights Ask An Analyst Here Competitive Landscape: The market is highly competitive. Boston Scientific Corporation, Olympus Corporation, EDAP TMS, DirexGroup and Accuron are among the key industry participants in the market. Moreover, certain strategic efforts, such as new product launches, mergers, collaborations and acquisitions are accepted by the corporations to assist them boost their market positions. Moreover, key players are also putting emphasis on the applications of lithotripsy devices in order to improve market share during the forecast period. Key Companies Profiled by Fact.MR EDAP TMS Boston Scientific Corporation Olympus Corporation Accuron DirexGroup Siemens AG Dornier MedTech STORZ Medical More Valuable Insights on Lithotripsy devices market Segmentation of Lithotripsy devices market Product Type Extracorporeal Shock Wave Lithotripsy Devices Intracorporeal Lithotripsy Devices Laser Lithotripsy Devices Electrohydraulic Lithotripsy Devices Ultrasonic Lithotripsy Devices Mechanical Lithotripsy Devices Application Lithotripsy Devices for Kidney Stones Lithotripsy Devices for Ureteral Stones Lithotripsy Devices for Pancreatic Stones Lithotripsy Devices for Bile Duct Stones End User Hospitals Ambulatory Surgical Centers Other End Users Get Customization on this Report for Specific Research Solutions Explore Fact.MR’s Coverage on the Healthcare Domain Asthma Treatment Market - Demand prospects for asthma therapeutics are likely to gain strength, owing to increasing awareness among patients regarding this condition. This should have led to linear growth of the asthma treatment market; however, a spurt in the sales of generic drugs, thriving on the back of patent expiration of branded drugs, is projected to limit market potential. Benzodiazepine Drugs Market - The trend of developing generic drugs holds relevance for prominent players such as Teva Pharmaceutical Industries Ltd. and Mylan N.V., who generate a sizeable revenue (around 58% market share) through the sales of generic products. Audiological Devices Market - The Hearing Loss Association of America (HLAA) advocates that auditory impairments account for the 3rd largest physical condition among people. Gradual hearing loss affects people of all ages, with varying degrees of deafness. Breast Surgery Retractors Market - Technological advancements in the areas of design and interface are expected to offer better usability to surgeons. On the back of these factors, the global breast surgery retractors market is projected to grow at a very modest CAGR of 3.3% during the forecast period (2020-2025). Guidewires Market - Advancements in guidewire tip technologies have increased the adoption of interventional radiology techniques in image-guided diagnosis and treatment of diseases. Interventional radiology has significantly improved patient recovery outcomes. Addiction Treatment Market - Addiction to various substances has been a major problem across the world. Abuse of substances such as alcohol, marijuana, cocaine, prescription medicine, tobacco, and others inflict debilitating damage to the human body. Out of these, tobacco consumption, mostly in the form of cigarette smoking, is a leading cause of death in the world. Contraceptives Market - The contraceptive devices segment shall contribute to the maximum growth of the contraceptives market. Contraceptive Devices are expected to account for more than 50% of the total contraceptives market share. Genetic Testing Services Market - Genetic testing services have come to be widely used for many applications in the fields of oncology, obstetrics and ancestry as well. These services are purported to assist clinicians and patients to identify hereditary factors leading to the outbreak of the diseases mentioned above Immunoassay Market - The global immunoassay market is forecast to grow at a 6% value CAGR, during the forecast period 2022-2032, reaching a market value of US$ 53 Billion. In 2021, the market was valued at US$ 28 Billion, and is likely to reach US$ 29.6 Billion in 2022, registering a Y-o-Y growth rate of 5.7%. About Fact.MR Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. 80% of Fortune 1000's trusts us in critical decision making. We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis. Contact: Mahendra Singh US Sales Office 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583 E: sales@factmr.com Follow Us: LinkedIn | Twitter